From the Ocular Surface and Tear Center, Department of Ophthalmology, Bascom Palmer Eye Institute, Miami (D.F.A., E.A., S.C.G.T.); the Department of Cell Biology & Anatomy, University of Miami School of Medicine, Miami (D.F.A., S.C.G.T.), Florida, U.S.A.; and the Department of Ophthalmology, Siriraj Hospital, Mahidol University, Bangkok, Thailand (P.P.).
Submitted September 25, 2000.
Revision received January 9, 2001.
Accepted January 10, 2001.
Supported in part by an unrestricted grant from Research to Prevent Blindness, Inc., New York, NY, U.S.A., and in part by a research fellowship grant (to D.F.A.) from the TFC Frost Charitable Trust, Esher, U.K.
Proprietary interest: S.C.G.T. has obtained a patent on preparation and clinical uses of amniotic membrane.
Address correspondence and reprint requests to S.C.G. Tseng, Bascom Palmer Eye Institute, William L. McKnight Vision Research Center, 1638 NW 10th Avenue, Miami, FL 33136, U.S.A. E-mail: [email protected]
